| Literature DB >> 31992235 |
Kang Yang1, Xiaodong Zhu2, Yulan Feng3, Fanxia Shen1, Jie Chen1, Ningzhen Fu4, Jialan Sun5, Yi Fu6.
Abstract
BACKGROUND: To investigate the relationships between blood pressure (BP) circadian rhythms and acute cerebral infarction (ACI), silent cerebral infarction (SCI) and the severity of leukoaraiosis in hypertensive patients.Entities:
Keywords: Acute cerebral infarction; Blood pressure circadian rhythms; Leukoaraiosis; Silent cerebral infarction
Mesh:
Year: 2020 PMID: 31992235 PMCID: PMC6988318 DOI: 10.1186/s12883-020-1626-6
Source DB: PubMed Journal: BMC Neurol ISSN: 1471-2377 Impact factor: 2.474
Fig. 1Flowchart of patient selection. ACI = acute cerebral infarction; SCI = silent cerebral infarction; ABPM = ambulatory blood pressure monitoring. Fifteen cases of ACI with hypertension less than 1 year and 24-h ABPM within 1 month of onset
Characteristics and demographics of ACI, SCI and control groups at baseline
| ACI group ( | SCI group ( | Control ( | |||
|---|---|---|---|---|---|
| Age | 66.8 ± 12.3 | 65.9 ± 12.8 | 57.8 ± 10.2 | <0.001 | <0.001 |
| Gender, Male | 342 (63.1%) | 255 (55.1%) | 105 (40.1%) | <0.001 | <0.001 |
| Smoking, Yes | 195 (36.0%) | 135 (29.2%) | 35 (13.4%) | <0.001 | <0.001 |
| Alcohol, Yes | 116 (21.4%) | 90 (19.4%) | 24 (9.2%) | <0.001 | <0.001 |
| Diabetes mellitus, Yes | 166 (30.6%) | 118 (25.5%) | 31 (11.8%) | <0.001 | <0.001 |
| Hypertension history (yrs) | 10.0 (5.0–20.0) | 10.0 (5.0–20.0) | 5.0 (2.0–10.0) | <0.001 | <0.001 |
| Hypertension family history, Yes | 46 (8.5%) | 202 (43.6%) | 79 (30.2%) | <0.001 | <0.001 |
| Oral medicine, Yes | |||||
| Antihypertension drugs | 480 (88.6%) | 396 (85.5%) | 252 (96.2%) | <0.001 | <0.001 |
| Antiplatelet drugs | 290 (53.5%) | 152 (32.8%) | 51 (19.5%) | <0.001 | <0.001 |
| Laboratory data | |||||
| Cholesterol, mmol/L | 4.7 ± 1.1 | 4.6 ± 1.0 | 4.6 ± 1.1 | 0.583 | 0.894 |
| Triglyceride, mmol/L | 1.8 ± 1.2 | 1.8 ± 1.1 | 1.8 ± 1.7 | 0.941 | 0.645 |
| HDL, mmol/L | 1.1 ± 0.3 | 1.2 ± 0.7 | 1.3 ± 0.9 | <0.001 | 0.013 |
| LDL, mmol/L | 2.9 ± 0.9 | 2.9 ± 1.0 | 2.9 ± 0.9 | 0.531 | 0.265 |
| FBG, mmol/L | 6.1 ± 2.3 | 5.5 ± 1.5 | 5.4 ± 1.3 | <0.001 | 0.542 |
| Urea nitrogen, mmol/L | 4.9 (4.1–5.9) | 5.1 (4.2–6.3) | 5.2 (4.2–6.8) | <0.001 | <0.001 |
| Creatinine, μmol/L | 72.0 (61.0–88.3) | 73.0 (58.0–86.3) | 61.0 (49.0–77.0) | <0.001 | <0.001 |
| Homocysteine, mmol/L | 14.6 ± 11.1 | 15.2 ± 11.4 | 12.7 ± 5.2 | 0.206 | 0.109 |
| TOAST | |||||
| AS | 429 (79.2%) | – | – | ||
| LS | 113 (20.8%) | – | – | ||
| Leukoaraiosis, Yes | 448 (82.7%) | 370 (79.9%) | – | ||
| Leukoaraiosis, PVWM | |||||
| Non | 98 (18.1%) | 95 (20.5%) | – | ||
| Mild | 122 (22.5%) | 139 (30.0%) | – | ||
| Moderate | 169 (31.2%) | 130 (28.1%) | – | ||
| Severe | 153 (28.2%) | 99 (21.4%) | – | ||
| Leukoaraiosis, DWM | – | ||||
| Non | 120 (22.1%) | 123 (26.6%) | – | ||
| Mild | 130 (24.0%) | 139 (30.0%) | – | ||
| Moderate | 117 (21.6%) | 97 (21.0%) | – | ||
| Severe | 175 (32.3%) | 104 (22.5%) | – | ||
| Moderate-Severe leukoaraiosis | 345 (63.7%) | 244 (52.7%) | – | ||
| NBPDR, % | 3.3 (−1.8–8.1) | 8.2 (1.8–14.2) | 7.9 (2.7–13.8) | <0.001 | 0.638 |
Abbreviations: ACI acute cerebral infarction, SCI silent cerebral infarction, HDL high-density lipoprotein cholesterol, LDL low-density lipoprotein cholesterol, FBG fasting blood glucose, TOAST Trial Ord 10,172 in acute stroke treatment, AS atherothrombotic stroke, LS lacunar stroke, PVWM periventricular hyperintensities, DWM deep white matter, NBPDR Nocturnal blood pressure drop rate. P1 and P2 refer to the comparisons of ACI group with control group and SCI group with control group separately
aResults are expressed as number (column %), mean ± SD, or median (interquartile range), as appropriate
Fig. 2Ambulatory blood pressure monitoring in patients. Compared with the control group, ACI and SCI patients had significantly higher diurnal mean SBP, diurnal MAP, nocturnal mean SBP, nocturnal mean DBP, nocturnal MAP, 24-h mean SBP, 24-h mean DBP, and 24-h mean arterial pressure (MAP). BP = blood pressure; SBP = systolic blood pressure; DBP = diastolic blood pressure; MAP = mean arterial pressure. *p<0.05, **p<0.001
Fig. 3BP circadian rhythm distribution in the ACI, SCI and control groups. In ACI patients, SCI patients and the control group, the respective number of individuals with each pattern of BP was as follows: reverse-dipper pattern: 186 (34.3%), 84 (18.1%), and 40 (15.3%); non-dipper pattern: 261 (48.2%), 193 (41.7%), and 123 (46.9%); dipper pattern: 83 (15.3%), 149 (32.2%), and 86 (32.8%); and extreme-dipper pattern: 12 (2.2%), 37 (8.0%), and 13 (5.0%)
Relevance between BP circadian rhythms and ACI or SCI groups
| Dipper pattern | Reverse-dipper pattern HR (95%CI) | Non-dipper pattern HR (95%CI) | Extreme-dipper pattern HR (95%CI) | |
|---|---|---|---|---|
| ACI group | ||||
| AS group | ||||
| Unadjusted | 1 [Reference] | 4.51 (2.8–7.2)** | 1.90 (1.3–2.8)** | 0.92 (0.4–2.2) |
| Adjusted | 1 [Reference] | 3.40 (2.0–5.8)** | 1.78 (1.1–2.8)* | 1.09 (0.4–3.0) |
| LS group | ||||
| Unadjusted | 1 [Reference] | 6.84 (3.2–14.8)** | 4.13 (2.1–8.3)** | 1.20 (0.2–6.1) |
| Adjusted | 1 [Reference] | 4.36 (1.8–10.6)** | 3.75 (1.7–8.2)** | 2.40 (0.4–14.8) |
| AS or LS group | ||||
| Unadjusted | 1 [Reference] | 4.82 (3.1–7.6)** | 2.20 (1.5–3.2)** | 0.92 (0.4–2.2) |
| Adjusted | 1 [Reference] | 3.50 (2.1–5.9)** | 2.00 (1.3–3.0)** | 1.16 (0.4–3.1) |
| SCI group | ||||
| Unadjusted | 1 [Reference] | 1.21 (0.8–1.9) | 0.91 (0.6–1.3) | 1.64 (0.8–3.3) |
| Adjusted | 1 [Reference] | 0.82 (0.5–1.4) | 0.91 (0.6–1.3) | 1.56 (0.7–3.3) |
Analysis focused on the comparisons as ACI group with control group and SCI group with control group separately, with the multivariate analysis adjustment on gender, age, smoking, diabetes, cholesterol, LDL and so on. AS atherothrombotic stroke, LS lacunar stroke, HR hazard ratio, CI confidence interval. (* P<0.05, ** P<0.001)
Comparison between leukoaraiosis severity and BP level together with different BP rhythms
| ACI group (N = 542) | SCI group (N = 463) | |||||
|---|---|---|---|---|---|---|
| Mild leukoaraiosis | Moderate-severe leukoaraiosis | Non leukoaraiosis | Mild leukoaraiosis | Moderate-severe leukoaraiosis | Non leukoaraiosis | |
| ( | ( | ( | ( | ( | ( | |
| BP, mmHg | ||||||
| Mean diurnal SBP | 141.6 ± 16.2 | 144.7 ± 18.3 | 142.1 ± 18.5 | 134.6 ± 14.4 | 139.5 ± 18.6** | 133.8 ± 14.0 |
| Mean diurnal DBP | 83.8 ± 11.6 | 80.3 ± 11.5** | 84.8 ± 10.5 | 79.3 ± 9.9 | 78.7 ± 12.0* | 82.1 ± 11.0 |
| Mean diurnal MAP | 103.1 ± 11.8 | 101.8 ± 12.2 | 103.9 ± 11.7 | 99.6 ± 11.0 | 103.4 ± 15.8* | 99.6 ± 10.6 |
| Mean nocturnal SBP | 134.6 ± 18.9 | 141.4 ± 20.7 | 136.7 ± 20.9 | 126.6 ± 17.1 | 136.4 ± 20.4** | 122.6 ± 14.9 |
| Mean nocturnal DBP | 79.9 ± 12.7 | 78.0 ± 12.3** | 81.5 ± 12.2 | 73.7 ± 10.6 | 75.4 ± 13.0 | 74.4 ± 10.4 |
| Mean nocturnal MAP | 98.1 ± 13.4 | 99.1 ± 13.5 | 99.9 ± 13.7 | 91.3 ± 11.3 | 95.8 ± 13.9** | 90.5 ± 10.9 |
| Mean 24-h SBP | 139.6 ± 16.1 | 143.4 ± 18.1 | 140.3 ± 18.7 | 132.2 ± 14.6 | 138.5 ± 18.1** | 130.4 ± 13.6 |
| Mean 24-h DBP | 82.7 ± 11.4 | 79.6 ± 11.1** | 83.8 ± 10.6 | 77.6 ± 9.8 | 77.7 ± 11.8 | 79.7 ± 10.5 |
| Mean 24-h MAP | 101.9 ± 12.2 | 101.9 ± 14.3 | 102.5 ± 11.8 | 97.8 ± 11.2 | 102.6 ± 15.8** | 96.8 ± 10.8 |
| NBPDR, % | 4.2 (−0.7–9.6) | 2.9 (− 2.5–7.3) | 3.7 (−1.1–8.2) | 8.1 (1.9–14.4) | 6.7 (0.7–14.1)* | 9.2 (5.1–13.7) |
| BP circadian rhythms classification | ||||||
| Reverse-dipper | 27 (26.7%) | 125 (36.2%) | 34 (35.4%) | 19 (14.8%) | 58 (23.8%) | 7 (7.7%) |
| Non-dipper | 52 (51.5%) | 165 (47.8%) | 44 (45.8%) | 58 (45.3%) | 94 (38.5%) | 41 (45.1%) |
| Dipper | 17 (16.8%) | 49 (14.2%) | 17 (17.7%) | 40 (31.3%) | 69 (28.3%) | 40 (44.0%) |
| Extreme-dipper | 5 (5.0%) | 6 (1.7%) | 1 (1.0%) | 11 (8.6%) | 23 (9.4%) | 3 (3.3%) |
*P<0.05, ** P<0.001
Relevance between leukoaraiosis severity and different BP circadian rhythms
| Relevance between mild leukoaraiosis and different BP circadian rhythms | Relevance between moderate-severe leukoaraiosis and different BP circadian rhythms | |||||||
|---|---|---|---|---|---|---|---|---|
| ACI group | SCI group | ACI group | SCI group | |||||
| OR (95% CI) | OR (95% CI) | OR (95% CI) | OR (95% CI) | |||||
| Unadjusted | ||||||||
| Dipper | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] |
| Reverse-dipper | 2.2 (1.1–4.3) | 0.022 | 1.3 (0.7–2.4) | 0.46 | 3.6 (2.3–5.5) | <0.001 | 2.3 (1.4–3.7) | 0.001 |
| Non-dipper | 1.9 (1.0–3.4) | 0.038 | 1.1 (0.7–1.8) | 0.649 | 2.0 (1.4–3.1) | <0.001 | 1.0 (0.7–1.5) | 0.818 |
| Extreme-dipper | 2.2 (0.7–6.8) | 0.186 | 2.2 (0.9–5.0) | 0.073 | 0.9 (0.3–2.5) | 0.84 | 2.6 (1.3–5.3) | 0.007 |
| Adjusted | ||||||||
| Dipper | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] | 1 [Reference] |
| Reverse-dipper | 1.8 (0.9–3.6) | 0.117 | 1.0 (0.5–2.0) | 0.986 | 2.1 (1.2–3.5) | 0.007 | 1.7 (0.9–3.0) | 0.047 |
| Non-dipper | 1.7 (0.9–3.2) | 0.106 | 1.2 (0.7–1.9) | 0.573 | 1.8 (1.1–3.0) | 0.012 | 1.1 (0.7–1.8) | 0.578 |
| Extreme-dipper | 2.9 (0.9–9.6) | 0.082 | 2.1 (0.8–5.1) | 0.117 | 0.8 (0.2–2.9) | 0.786 | 2.9 (1.2–7.0) | 0.015 |
Multivariate analysis adjusted the factors such as gender, age, smoking, diabetes, cholesterol, LDL and so on